Apyx Medical Corporation
APYX
$0.975
$0.0454.84%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 51.83% | -1.60% | -559.56% | -117.51% | -58.82% |
| Total Depreciation and Amortization | -6.58% | -22.58% | 3.31% | -22.66% | -24.75% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -61.06% | -19.92% | 296.98% | 12.07% | 187.44% |
| Change in Net Operating Assets | -117.49% | -119.17% | 121.13% | -301.92% | 637.71% |
| Cash from Operations | -32.78% | -220.13% | 10.78% | -237.11% | 51.17% |
| Capital Expenditure | -163.44% | 12.07% | -85.26% | 68.18% | 34.51% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -163.44% | 12.07% | -104.06% | 68.18% | 34.51% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 99.95% | 61.54% | 50.00% | 44.44% | -110,250.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -133.86% | -- | -- | -- | -- |
| Cash from Financing | -71.65% | -103.05% | -110.87% | -100.06% | 238,540.00% |
| Foreign Exchange rate Adjustments | 814.29% | -116.13% | 123.46% | 118.97% | -151.22% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -82.67% | -227.63% | -307.01% | -205.06% | 563.65% |